Agenda:

Welcome & Introductions

Mpox Vaccine

• Introduction
• JYNNEOS for 12-17 year olds
• Outbreaks

Lyme Disease Vaccine

Influenza Vaccines

• Introduction
• Effectiveness
• FluMist administration

COVID-19 Vaccines

• Introduction
• Moderna mRNA-1283
• Hospitalization epidemiology and risk factors
• Effectiveness
• 2026-2026 considerations

Pneumococcal Vaccines

• Work plan proposition

HPV Vaccines

• Introduction
• Dosage literature
• KEN SHE trial
• Coverage
• Reduced dose modeling
• Age for routine immunization
• Next steps

CMV Vaccines

• Introduction
• Epidemiology and disease burden
• Safety and immunogenicity
• Policy considerations

U.S. Measles Update